Drugs

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

Drugs
Nov 18, 2024, 14:07 | Drugs
IDRx Announces Updated Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial of IDRX-42
IDRx Announces Updated Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial of IDRX-42…
Nov 17, 2024, 07:41 | Drugs
Breakthrough GD2-CAR T-Cell Therapy Shows Promise for Pediatric Brain Cancer
GD2-CAR T-Cell Therapy Offers New Hope for Pediatric Brain Cancer The clinical study on GD2-CAR…
Nov 9, 2024, 14:35 | Drugs
FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia
The FDA has broadened its approval of methotrexate (Jylamvo) to include the treatment of pediatric…
Nov 8, 2024, 18:35 | Drugs
Do adjuvant aromatase inhibitors increase risk of ischaemic cardiotoxicity in postmenopausal patients with early breast cancer?
Erman Akkus shared a post on X: ''Do adjuvant aromatase inhibitors increase risk of ischaemic…
Nov 4, 2024, 17:12 | Drugs
Talha Badar: Current FDA label for asciminib
Talha Badar, Hematologist at Mayo Clinic Comprehensive Cancer Center, shared a post on X: ''Deep dive…
Nov 4, 2024, 16:51 | Drugs
Rahul Banerjee: What Changes Once SQ Isatuximab Approved?
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared…
Oct 31, 2024, 09:57 | Drugs
£3m for world-first trial to revolutionise brain cancer treatment - Cancer Research UK
Cancer Research UK shared on LinkedIn: "A pioneering UK-wide trial has been awarded over £3m,…
Oct 31, 2024, 08:27 | Drugs
FDA grants accelerated approval to asciminib for newly diagnosed CML
On October 29, 2024, the FDA granted accelerated approval for asciminib (Scemblix, Novartis AG)  to…
Oct 30, 2024, 16:37 | Drugs
Ivonescimab in Combination Therapy for Extensive-Stage Small Cell Lung Cancer
Ivonescimab: Evaluating Safety, Tolerance, and Efficacy of a Novel Bispecific Antibody Treatment Ivonescimab, a humanized…
Oct 26, 2024, 10:21 | Drugs
Health Canada Approves First and Only Oral Targeted Treatment for Brain Cancer
LAVAL, QC, Oct. 22, 2024 /CNW/ – Servier Canada is pleased to announce the approval and commercial availability…
All: 419 Posts: 1 - 10
Special Coverage